BB BIOTECH AG 13D and 13G filings for MacroGenics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 2:39 pm Unchanged | 2024-12-31 | 13G | MacroGenics, Inc. MGNX | BB BIOTECH AG | 9,929,963 15.800% | 0 (Unchanged) | Filing |
| 2024-02-13 06:13 am Purchase | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | BB BIOTECH AG | 9,929,963 16.000% | 1,000,000 (+11.20%) | Filing |
| 2023-02-14 4:09 pm Purchase | 2022-12-31 | 13G | MacroGenics, Inc. MGNX | BB BIOTECH AG | 8,929,963 14.500% | 1,654,399 (+22.74%) | Filing |
| 2022-02-11 4:38 pm Purchase | 2021-12-31 | 13G | MacroGenics, Inc. MGNX | BB BIOTECH AG | 7,275,564 11.900% | 1,250,000 (+20.74%) | Filing |
| 2021-06-11 5:25 pm Purchase | 2021-06-09 | 13G | MacroGenics, Inc. MGNX | BB BIOTECH AG | 6,025,564 10.000% | 1,210,000 (+25.13%) | Filing |
| 2021-02-12 4:40 pm Purchase | 2020-12-31 | 13G | MacroGenics, Inc. MGNX | BB BIOTECH AG | 4,815,564 8.600% | 296,405 (+6.56%) | Filing |